$4.97
0.091.95%
Pre-Market: 8:50 AM EDT
Comments
Loading...
ImmunityBio (NASDAQ:IBRX) Stock Quotes, Forecast and News Summary
ImmunityBio Stock (NASDAQ: IBRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ImmunityBio (IBRX) stock?
You can purchase shares of ImmunityBio (NASDAQ:IBRX) through any online brokerage.
Who are ImmunityBio (IBRX) competitors?
Other companies in ImmunityBio’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), Alkermes (NASDAQ:ALKS) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the forecast, or price target, for ImmunityBio (IBRX) stock?
ImmunityBio has a consensus price target of $18.19.
What is the current price for ImmunityBio (IBRX)?
The stock price for ImmunityBio (NASDAQ: IBRX) is $4.97 last updated November 21, 2024 at 8:50 AM EST.
Does ImmunityBio (IBRX) pay a dividend?
There are no upcoming dividends for ImmunityBio.
When is ImmunityBio (NASDAQ:IBRX) reporting earnings?
ImmunityBio’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is ImmunityBio (IBRX) going to split?
There is no upcoming split for ImmunityBio.
What sector and industry does ImmunityBio (IBRX) operate in?
ImmunityBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.